Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thor Tejada

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Diabetes Reviews|January 29, 2008
Role of inflammation in diabetic nephropathyAlessia Fornoni, Adeel Ijaz, Thor Tejada, et al.
Current Hypertension Reports|August 10, 2007
Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?Thor Tejada, Alessia Fornoni, Oliver Lenz, et al.
Current Cardiology Reports|October 25, 2006
Nonpharmacologic therapy for hypertension: does it really work?Thor Tejada, Alessia Fornoni, Oliver Lenz, et al.
Heartrhythm Case Reports|May 1, 2018
Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulatorsThor Tejada, Faisal M Merchant, Mikhael F El-Chami
Journal of Magnetic Resonance Imaging : JMRI|May 31, 2017
Combined Angiography and Late Gadolinium Enhancement Acquisition to Improve Assessment of Pulmonary Vein Isolation for Atrial FibrillationAdrian Lam, Erica Okene, Ankit Parikh, et al.
Heart Rhythm|January 13, 2018
Procedural outcomes and long-term survival associated with lead extraction in patients with abandoned leadsFaisal M Merchant, Thor Tejada, Adarsh Patel, et al.
Kidney International|October 31, 2008
Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetesAdeel Ijaz, Thor Tejada, Paola Catanuto, et al.
American Journal of Cardiovascular Disease|September 29, 2016
Angiotensin type 2-receptor (AT2R) activation induces hypotension in apolipoprotein E-deficient mice by activating peroxisome proliferator-activated receptor-γMing Li, Thor Tejada, Jonathan P Lambert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarctionThor Tejada, Lin Tan, Rebecca A Torres, et al.
Congenital Heart Disease|September 7, 2016
"Frontiers in Fontan failure: A summary of conference proceedings"Camden Hebson, Wendy Book, Robert W Elder, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Diabetes Reviews|January 29, 2008
Role of inflammation in diabetic nephropathyAlessia Fornoni, Adeel Ijaz, Thor Tejada, et al.
Current Hypertension Reports|August 10, 2007
Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?Thor Tejada, Alessia Fornoni, Oliver Lenz, et al.
Current Cardiology Reports|October 25, 2006
Nonpharmacologic therapy for hypertension: does it really work?Thor Tejada, Alessia Fornoni, Oliver Lenz, et al.
Heartrhythm Case Reports|May 1, 2018
Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulatorsThor Tejada, Faisal M Merchant, Mikhael F El-Chami
Journal of Magnetic Resonance Imaging : JMRI|May 31, 2017
Combined Angiography and Late Gadolinium Enhancement Acquisition to Improve Assessment of Pulmonary Vein Isolation for Atrial FibrillationAdrian Lam, Erica Okene, Ankit Parikh, et al.
Heart Rhythm|January 13, 2018
Procedural outcomes and long-term survival associated with lead extraction in patients with abandoned leadsFaisal M Merchant, Thor Tejada, Adarsh Patel, et al.
Kidney International|October 31, 2008
Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetesAdeel Ijaz, Thor Tejada, Paola Catanuto, et al.
American Journal of Cardiovascular Disease|September 29, 2016
Angiotensin type 2-receptor (AT2R) activation induces hypotension in apolipoprotein E-deficient mice by activating peroxisome proliferator-activated receptor-γMing Li, Thor Tejada, Jonathan P Lambert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarctionThor Tejada, Lin Tan, Rebecca A Torres, et al.
Congenital Heart Disease|September 7, 2016
"Frontiers in Fontan failure: A summary of conference proceedings"Camden Hebson, Wendy Book, Robert W Elder, et al.
Pageof 2